Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 3
2009 5
2010 11
2011 18
2012 20
2013 24
2014 19
2015 33
2016 40
2017 45
2018 44
2019 43
2020 26
Text availability
Article attribute
Article type
Publication date

Search Results

291 results
Results by year
Filters applied: . Clear all
Page 1
microRNAs in cardiovascular disease - clinical application.
Schulte C, Karakas M, Zeller T. Schulte C, et al. Clin Chem Lab Med. 2017 May 1;55(5):687-704. doi: 10.1515/cclm-2016-0576. Clin Chem Lab Med. 2017. PMID: 27914211 Free article. Review.
In cardiovascular disease (CVD), numerous studies have suggested miRNAs as strong circulating biomarkers with high diagnostic as well as prognostic power. ...Attempts to utilize miRNAs as therapeutic agents have led to promising results. In this article, we r …
In cardiovascular disease (CVD), numerous studies have suggested miRNAs as strong circulating biomarkers with high diagnostic …
MicroRNAs in Cardiovascular Disease.
Barwari T, Joshi A, Mayr M. Barwari T, et al. J Am Coll Cardiol. 2016 Dec 13;68(23):2577-2584. doi: 10.1016/j.jacc.2016.09.945. J Am Coll Cardiol. 2016. PMID: 27931616 Free article. Review.
This includes the potential of miRNAs as therapeutic targets in cardiac and vascular disease, and their use as novel biomarkers. ...The development of more targeted interventions will bolster well-informed clinical applications, increasing the chances of succ …
This includes the potential of miRNAs as therapeutic targets in cardiac and vascular disease, and their use as novel biomarker …
miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart.
Bernardo BC, Ooi JY, Lin RC, McMullen JR. Bernardo BC, et al. Future Med Chem. 2015;7(13):1771-92. doi: 10.4155/fmc.15.107. Epub 2015 Sep 24. Future Med Chem. 2015. PMID: 26399457 Review.
Here, the authors describe the contribution of miRNAs to cardiac biology and disease. They discuss various strategies for manipulating miRNA activity including antisense oligonucleotides (antimiRs, blockmiRs), mimics, miRNA sponges, Tough Decoys and miRNA mowers. ...They s …
Here, the authors describe the contribution of miRNAs to cardiac biology and disease. They discuss various strategies for manipulatin …
Noncoding RNAs in Cardiovascular Disease: Pathological Relevance and Emerging Role as Biomarkers and Therapeutics.
Gangwar RS, Rajagopalan S, Natarajan R, Deiuliis JA. Gangwar RS, et al. Am J Hypertens. 2018 Jan 12;31(2):150-165. doi: 10.1093/ajh/hpx197. Am J Hypertens. 2018. PMID: 29186297 Free PMC article. Review.
Cardiovascular morbidity is associated with differential expression of myriad miRNAs; miR-21, miR-155, miR-126, miR-146a/b, miR-143/145, miR-223, and miR-221 are the top 9 most reported miRNAs in hypertension and atherosclerotic disease. ..."Immuno-miRs", such as mi
Cardiovascular morbidity is associated with differential expression of myriad miRNAs; miR-21, miR-155, miR-126, miR-146a/b, miR-143/1
Non-coding RNA in endothelial-to-mesenchymal transition.
Hulshoff MS, Del Monte-Nieto G, Kovacic J, Krenning G. Hulshoff MS, et al. Cardiovasc Res. 2019 Oct 1;115(12):1716-1731. doi: 10.1093/cvr/cvz211. Cardiovasc Res. 2019. PMID: 31504268 Free PMC article. Review.
Non-coding RNAs, including microRNAs, long non-coding RNAs, and circular RNAs, modulate EndMT during development and disease. Here, we review the mechanisms by which non-coding RNAs facilitate or inhibit EndMT during development and disease and provide a pers …
Non-coding RNAs, including microRNAs, long non-coding RNAs, and circular RNAs, modulate EndMT during development and disease. …
Extracellular Vesicles in Cardiovascular Diseases: Alternative Biomarker Sources, Therapeutic Agents, and Drug Delivery Carriers.
Chong SY, Lee CK, Huang C, Ou YH, Charles CJ, Richards AM, Neupane YR, Pavon MV, Zharkova O, Pastorin G, Wang JW. Chong SY, et al. Int J Mol Sci. 2019 Jul 3;20(13):3272. doi: 10.3390/ijms20133272. Int J Mol Sci. 2019. PMID: 31277271 Free PMC article. Review.
Cardiovascular diseases (CVD) represent the leading cause of morbidity and mortality globally. The emerging role of extracellular vesicles (EVs) in intercellular communication has stimulated renewed interest in exploring the potential application of EVs as to
Cardiovascular diseases (CVD) represent the leading cause of morbidity and mortality globally. The emerging role of extracellu
Molecular roles and function of circular RNAs in eukaryotic cells.
Holdt LM, Kohlmaier A, Teupser D. Holdt LM, et al. Cell Mol Life Sci. 2018 Mar;75(6):1071-1098. doi: 10.1007/s00018-017-2688-5. Epub 2017 Nov 7. Cell Mol Life Sci. 2018. PMID: 29116363 Free PMC article. Review.
We describe how circRNAs impact gene expression of their host gene locus by affecting transcriptional initiation and elongation or splicing, and how they partake in controlling the function of other molecules, for example by interacting with microRNAs and proteins. We conc …
We describe how circRNAs impact gene expression of their host gene locus by affecting transcriptional initiation and elongation or splicing, …
microRNA-based diagnostics and therapy in cardiovascular disease-Summing up the facts.
Schulte C, Zeller T. Schulte C, et al. Cardiovasc Diagn Ther. 2015 Feb;5(1):17-36. doi: 10.3978/j.issn.2223-3652.2014.12.03. Cardiovasc Diagn Ther. 2015. PMID: 25774345 Free PMC article. Review.
Circulating microRNAs (miRNAs) are discussed as potential disease-specific biomarkers in cardiovascular disease. Their diagnostic value has been examined in numerous studies and animal models with respect to coronary artery disease (CAD) and myo …
Circulating microRNAs (miRNAs) are discussed as potential disease-specific biomarkers in cardiovascular disease. …
Exosomes: Fundamental Biology and Roles in Cardiovascular Physiology.
Ibrahim A, Marbán E. Ibrahim A, et al. Annu Rev Physiol. 2016;78:67-83. doi: 10.1146/annurev-physiol-021115-104929. Epub 2015 Nov 30. Annu Rev Physiol. 2016. PMID: 26667071 Free PMC article. Review.
Exosomal microRNAs in particular can potently and fundamentally alter the transcriptome of recipient cells. Here we summarize what is known about exosome biogenesis, content, and transmission, with a focus on cardiovascular physiology and pathophysiology. We also hi …
Exosomal microRNAs in particular can potently and fundamentally alter the transcriptome of recipient cells. Here we summarize what is …
Regenerative Cardiovascular Therapies: Stem Cells and Beyond.
Wernly B, Mirna M, Rezar R, Prodinger C, Jung C, Podesser BK, Kiss A, Hoppe UC, Lichtenauer M. Wernly B, et al. Int J Mol Sci. 2019 Mar 21;20(6):1420. doi: 10.3390/ijms20061420. Int J Mol Sci. 2019. PMID: 30901815 Free PMC article. Review.
Translation from an animal model to stem cell application in a clinical setting was rapid and the first large trials in humans suffering from AMI were conducted. ...Hence, we provide an overview of both basic science and clinical trials carried out in regenerative cardi
Translation from an animal model to stem cell application in a clinical setting was rapid and the first large trials in humans suffer …
291 results
Jump to page
Feedback